None of the mice bearing control EO771 tumors responded to PD-1 blockade (Fig. 6c) and Nedd8 deficiency did not delay tumor growth when treated with the isotype control antibody, as compared to mice bearing control tumors (Supplementary Fig. 7e). This evidence concerns the gene NEDD8 and neoplasm.